Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04038099 · ClinicalTrials.gov registry record · Phase 4
Lessons on Urethral Lidocaine in Urodynamics
A Phase 4 study, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 63
- Enrollment target
NCT04038099 is a Phase 4 study that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 63 participants.
The verdict
NCT04038099, a Phase 4 study, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 63 participants
- Enrollment target
Study Summary
This trial will assess whether use of intraurethral 2% lidocaine jelly meaningfully impacts sensation during filling (i.e., a change of more than 25% of first sensation, first desire to void, strong desire to void, or maximum cystometric capacity) and determine whether the use of intraurethral 2% lidocaine jelly meaningfully impacts pain/discomfort, filling metrics, and voiding metrics.
Interventions
- DRUG Water-Based Vaginal Lubricant
- DRUG lidocaine topical
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63 participants |
| Start Date | 2019-08-14 |
| Est. Completion | 2021-08-18 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04038099
The ClinicalTrials.gov registry entry for NCT04038099 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 63 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Water-Based Vaginal Lubricant is the first listed.
NCT04038099 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04038099 about?
NCT04038099 is a clinical study titled "Lessons on Urethral Lidocaine in Urodynamics". This trial will assess whether use of intraurethral 2% lidocaine jelly meaningfully impacts sensation during filling (i.e., a change of more than 25% of first sensation, first desire to void, strong desire to void, or maximum cystometric capacity) and determine whether the use of intraurethral 2% li...
What is the current status of trial NCT04038099?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 63 participants. The study started on 2019-08-14. Estimated completion is 2021-08-18.
What interventions are being tested in trial NCT04038099?
The interventions under investigation include: Water-Based Vaginal Lubricant (DRUG), lidocaine topical (DRUG).
Who is sponsoring clinical trial NCT04038099?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.